The special mass shift coefficient and field parameter factor of four multiples,3s^4P→3p4P°,3s^4P→3p^4D°,3s^2D→5p^2D°,and 3s^2P→3p^2P°,of ^14N and ^15N were studied using the multi-configuratio...The special mass shift coefficient and field parameter factor of four multiples,3s^4P→3p4P°,3s^4P→3p^4D°,3s^2D→5p^2D°,and 3s^2P→3p^2P°,of ^14N and ^15N were studied using the multi-configuration Dirac-Hartree-Fock method and the relativistic configuration interaction approach.The normal mass shifts,special mass shifts,field shifts,and isotope shifts of N(I)were derived from the theoretical calculated normal mass shift parameter,special mass shift parameter and field parameter factor,and compared with the reported experimental measurements and theoretical results.展开更多
Validity of adiabatic assumption is discussed within the constrained Hartree-Fock theory for self-conjugate nucleus ~(72)Kr.It is shown that the adiabatic assumption does not provide a correct description for the natu...Validity of adiabatic assumption is discussed within the constrained Hartree-Fock theory for self-conjugate nucleus ~(72)Kr.It is shown that the adiabatic assumption does not provide a correct description for the nature of nucleus when a configuration change is involved.The excited Hartree-Fock states and the continuously-connected constrained Hartree-Fock states are given for the first time by applying the configuration dictated constrained Hartree-Fock theory with Gogny force.The importance of self-consistency between the mean-field and the single particle wave functions is emphasized even when a small number of nucleons are involved in the configuration change.展开更多
This paper presents the results of a pre-clinical study of the immunogenicity and efficacy of an egg-derived, inactivated, whole-virion adjuvanted vaccine （Refluvac） on ferret models. For this purpose, groups of eig...This paper presents the results of a pre-clinical study of the immunogenicity and efficacy of an egg-derived, inactivated, whole-virion adjuvanted vaccine （Refluvac） on ferret models. For this purpose, groups of eight ferrets （6 to 7 months old） were injected with 0.5 mL of vaccine specimens containing 3.75, 7.5 or 15.0 μg of virus hemagglutinin. Administration was intramuscular and given either as a single dose or as two doses 14 days apart. All vaccine specimens manifested immunogenicity in ferrets for single （HI titer, from 51 ± 7 to 160 ± 23） and double （HI titer, from 697± 120 to 829 ± 117） administrations. To assess the protective effects of the vaccine, ferrets from the vaccinated and control groups were infected intranasally with pandemic virus A/California/7/09 （H1N1） pdm09 at a dose of 106 106/0.5 mL. Fourteen days post-infection, the ferrets inoculated with single or double vaccines containing 3.75, 7.5 or 15.0 ~g of hemagglutinin per dose showed no signs of influenza infection, weight loss, or body temperature rise, and no premature deaths occurred. The number of vaccinated ferrets shedding the virus via the upper airway, as well as the amount of virus shed after infection, was significantly reduced in comparison with animals from the control group. Based on our results, we suggest that a single vaccination at a dose of 3.75 or 7.5 μg hemagglutinin be used for Phase I clinical trials.展开更多
基金supported by the National Natural Science Foundation of China(No.11674096,No.11874151,and No.11834003)Shanghai Pujiang Talents Plan(No.18PJ1403100).
文摘The special mass shift coefficient and field parameter factor of four multiples,3s^4P→3p4P°,3s^4P→3p^4D°,3s^2D→5p^2D°,and 3s^2P→3p^2P°,of ^14N and ^15N were studied using the multi-configuration Dirac-Hartree-Fock method and the relativistic configuration interaction approach.The normal mass shifts,special mass shifts,field shifts,and isotope shifts of N(I)were derived from the theoretical calculated normal mass shift parameter,special mass shift parameter and field parameter factor,and compared with the reported experimental measurements and theoretical results.
基金The project supported in part by the Japanese Society for the Promotion of Science (JSPS) and National Natural Science Foundation of China as the bilateral program between Japan and China.One of the authors (E.G.Zhao) acknowledges the support by National
文摘Validity of adiabatic assumption is discussed within the constrained Hartree-Fock theory for self-conjugate nucleus ~(72)Kr.It is shown that the adiabatic assumption does not provide a correct description for the nature of nucleus when a configuration change is involved.The excited Hartree-Fock states and the continuously-connected constrained Hartree-Fock states are given for the first time by applying the configuration dictated constrained Hartree-Fock theory with Gogny force.The importance of self-consistency between the mean-field and the single particle wave functions is emphasized even when a small number of nucleons are involved in the configuration change.
文摘This paper presents the results of a pre-clinical study of the immunogenicity and efficacy of an egg-derived, inactivated, whole-virion adjuvanted vaccine （Refluvac） on ferret models. For this purpose, groups of eight ferrets （6 to 7 months old） were injected with 0.5 mL of vaccine specimens containing 3.75, 7.5 or 15.0 μg of virus hemagglutinin. Administration was intramuscular and given either as a single dose or as two doses 14 days apart. All vaccine specimens manifested immunogenicity in ferrets for single （HI titer, from 51 ± 7 to 160 ± 23） and double （HI titer, from 697± 120 to 829 ± 117） administrations. To assess the protective effects of the vaccine, ferrets from the vaccinated and control groups were infected intranasally with pandemic virus A/California/7/09 （H1N1） pdm09 at a dose of 106 106/0.5 mL. Fourteen days post-infection, the ferrets inoculated with single or double vaccines containing 3.75, 7.5 or 15.0 ~g of hemagglutinin per dose showed no signs of influenza infection, weight loss, or body temperature rise, and no premature deaths occurred. The number of vaccinated ferrets shedding the virus via the upper airway, as well as the amount of virus shed after infection, was significantly reduced in comparison with animals from the control group. Based on our results, we suggest that a single vaccination at a dose of 3.75 or 7.5 μg hemagglutinin be used for Phase I clinical trials.
